Drug Trial Radar · NCT01139216
Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
Last checked: Nov 19, 2026Latest source record: Jan 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
45
Actual
Start
Aug 2010
Primary completion
Nov 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Tsumura USAIndustry
- Sponsor type
- Industry
- Collaborators
- Cato Research
- First posted
- Jun 8, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the dose-related effects of TU-100, a botanical agent that modulates gastrointestinal nerves, on rectal compliance, rectal sensation thresholds and small bowel and colonic transit in female patients with functional constipation as compared to placebo.
Conditions
- Functional Constipation
- Gastric Emptying
- Whole Gut Transit
- Small Bowel Transit
- Colonic Transit
- Rectal Compliance
- Rectal Sensation
Interventions
Daikenchuto (TU-100)Drug
Subjects will receive 2.5g TID (7.5g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
Daikenchuto (TU-100)Drug
Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
PlaceboDrug
Subjects will receive daily dose of TU-100 placebo. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Colonic geometric center at 24 hours measured by scintigraphyTime frame: Up to 48 hours
- T1/2 of ascending colon emptying as measured by scintigraphyTime frame: Up to 48 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic, Rochester Methodist CRU
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.